The incretin effect, which is responsible for up to 50% of the normal release of insulin following oral glucose ingestion, is significantly reduced in Type 2 diabetes [23], due both to the diabetes itself and to concomitant obesity [24]. The gene discussed is GCG; the disease is type 2 diabetes mellitus.